Provided by Tiger Trade Technology Pte. Ltd.

Eton Pharmaceuticals, Inc.

63.47
+3.565.94%
Post-market: 63.940.4700+0.74%19:44 EDT
Volume:640.79K
Turnover:40.08M
Market Cap:1.81B
PE:162.74
High:64.00
Open:59.76
Low:59.76
Close:59.91
52wk High:64.00
52wk Low:14.27
Shares:28.58M
Float Shares:26.68M
Volume Ratio:0.56
T/O Rate:2.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3900
EPS(LYR):-0.1710
ROE:35.97%
ROA:11.86%
PB:38.94
PE(LYR):-371.19

Loading ...

Eton Pharmaceuticals Initiated at Buy by Canaccord Genuity

Dow Jones
·
Jul 17

Opaleye Management Disposes of 28,315 Eton Pharma Shares Worth $1.06 Million

Reuters
·
Jul 17

Eton Pharmaceuticals initiated with a Buy at Canaccord

TIPRANKS
·
Jul 17

Opaleye Management Sells 126,685 Eton Pharma Shares for $4.8 Million

Reuters
·
Jul 08

Analysts Offer Insights on Healthcare Companies: Eton Pharmaceuticals (ETON), Tarsus Pharmaceuticals (TARS) and Arrowhead Pharmaceuticals (ARWR)

TIPRANKS
·
Jul 06

Analysts’ Top Healthcare Picks: Eton Pharmaceuticals (ETON), Arrowhead Pharmaceuticals (ARWR)

TIPRANKS
·
Jun 27

Eton Pharma director Jennifer McKie Adams disposes of 50,000 common shares for $1.62 million

Reuters
·
Jun 18

Eton Pharmaceuticals shareholders elect two directors at annual meeting

Reuters
·
Jun 10

Eton Pharma CFO Judith Matthews files initial beneficial ownership statement

Reuters
·
Jun 02

Eton Pharma CEO Sean Brynjelsen sells common shares worth $3.87 million

Reuters
·
May 30

Eton Pharma Chief Business Officer David Krempa disposes of 99,999 common shares worth USD 3.24 million

Reuters
·
May 28

Analysts Are Bullish on These Healthcare Stocks: Personalis (PSNL), Eton Pharmaceuticals (ETON)

TIPRANKS
·
May 22

Eton Pharmaceuticals secures US commercialization rights to leishmaniasis drug Impavido

Reuters
·
May 20

Eton Pharmaceuticals Inc - Exclusive U.S. Commercialization Rights to Impavido Effective September 26, 2026

THOMSON REUTERS
·
May 20

Eton Pharmaceuticals Expands Rare Disease Portfolio Through Agreement for U.S. Commercialization Rights to Impavido® (Miltefosine)

THOMSON REUTERS
·
May 20

Eton Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 16

Eton Pharmaceuticals, Inc. : H.c. Wainwright Raises Target Price to $57 From $52

THOMSON REUTERS
·
May 15

Eton Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 15

Eton Pharma swings to Q1 FY26 profit of $1.55 million; revenue rises to $24.27 million

Reuters
·
May 15

Eton Pharmaceuticals Q1 product sales rise driven by portfolio expansion

Reuters
·
May 15